An increasing body of literature now supports the fact that CDR1as is deregulated in many types of cancers, such as bladder cancer, liver cancer, nasopharyngeal cancer, and esophageal squamous cell cancer (Zhong et al., 2019, Meng et al., 2020). This evidence concerns the gene LINC00632 and esophageal squamous cell carcinoma.